ECP 2019 Final Programme

70 Monday, 9 Sept ECP 2019 · Nice Two-Day Molecular Pathology Diagnostics Symposium e Monday, 9 September 2019 MD-01 2-Day MD Symposium 08:30–09:30 Clio Selected Abstracts Chairs: Cristina Teixeido, Spain Bastiaan Tops, The Netherlands 001 08:30–08:42 Plasma cfDNA testing of patients with EGFR mutant non-small cell lung cancer: droplet-digital PCR versus next-generation sequencing compared to tissue-based results Hendrikus Jan Dubbink, The Netherlandss P. N. Atmodimedjo, E. de Jonge, M. Paats, C. van der Leest, E. Oomen - de Hoop, J. von der Thüsen, W. Dinjens, R. H. van Schaik, J. Aerts, C. M. J. Steendam 002 08:42–08:54 Circulating Cell-free DNA in archived low quality volume serum samples: Rate of concordance with mutation in tumour Behnoush Abedi-Ardekani, France D. Nasrollahzadeh, T. Delhomme, P. H. Avogbe, M. Foll, J. McKay, P. Brennan, R. Malekzadeh 003 08:54–09:06 Global delivery of external quality assessment for lung cancer liquid biopsy testing Zandra Deans, United Kingdom J. Fairley, M. Cheetham, M. Denis, E. Dequeker, C. Keppens, F. Fenizia, N. Normanno, S. Patton, E. Rouleau, E. Schuuring, K. van Casteren 004 09:06–09:18 Reflex tumour BRCA1/2 testing in ovarian carcinomas to stratify PARP inhibitor treatment and germline diagnostics Marjolijn Ligtenberg, The Netherlands J. R. Vos, I. E. Fakkert, J. A. de Hullu, A. M. van Altena, A. S. Sie, H. Ouchene, R. W. Willems, I. Nagtegaal, M. C. Jongmans, A. R. Mensenkamp, G. H. Woldringh, J. Bulten, E. M. Leter, C. M. Kets, M. Simons, N. Hoogerbrugge 005 09:18–09:30 Exploitation of cfDNA extracted from bile as liquid biopsy source in pancreatobiliary cancers Caroline Driescher, Germany K. Ebner, W. Goering, L. Haeberle, V. Keitel, D. Haeussinger, I. Esposito MD-02 2-Day MD Symposium 10:30–12:00 Clio Preanalytics Chairs: Frederick Klauschen, Germany Erik Jan Dubbink, The Netherlands 001 10:30–11:00 Where a reliable biomarker is born: a new pathology preanalytics in XXIst century Antonio Martinez, Spain 002 11:00–11:30 Parallel sequencing after cell separation from FFPE material Janna Siemanowski, Germany (supported by Miltenyi Biotec) 003 11:30–12:00 Suitability of cytological specimen for NGS testing Giancarlo Troncone, Italy MD-03 2-Day MD Symposium 14:45–16:45 Clio Quality assurance and guidelines in molecular pathology Chairs: Nicola Normanno, Italy Etienne Rouleau, France 001 14:45–15:09 ESP EQAs: impact on quality improvement Aleš Ryška, Czech Republic 002 15:09–15:33 IQN PATH: ring trial on TMB testing Francesca Fenizia, Italy 003 15:33–15:39 IQN PATH: ring trial on liquid biopsy – introduction of trial concept Jennifer Fairley, United Kingdom 004 15:39–15:57 IQN PATH: ring trial on liquid biopsy – results from the ESP-EQA Kaat van Casteren, Belgium